Quick Takeaways: Why It Matters? Data for LPT‑CBD strengthens the scientific case for long‑acting, injectable CBD as a legitimate chronic pain option, not just a wellness supplement, which can increase veterinarian openness to cannabinoid-based therapies. The sustaine...
Quick Takeaways: Why It Matters? The deal broadens Greenies’ reach in the vet channel, making it easier for clinics to stock dental treats and Pill Pockets as everyday compliance tools. By adding a major brand, epiq enhances its importance as a distribution partn...
Quick Takeaways: Why It Matters? With both TAS and RXE accepted, Loyal moves significantly closer to commercializing the first true longevity drug in veterinary medicine, turning canine lifespan extension into a near-term, rather than speculative, market. If LOY-002 reache...
